Lupus Nephritis
Lupus nephritis, one of the most serious manifestations of systemic lupus erythematosus (SLE), usually arises within 5 years of diagnosis; however, renal failure rarely occurs before American College of…
emedicine.medscape.com
Pathophysiology and Treatment of Human Lupus Nephritis
Gain a better understanding of the pathophysiology of lupus nephritis and learn about the best therapeutic strategies for this disease.
www.medscape.com
Update on Lupus Nephritis
SLE is a chronic inflammatory disease that affects the kidneys in about 50% of patients. Lupus nephritis is a major risk factor for overall morbidity and mortality in SLE, and despite potent anti-inflammatory and immunosuppressive therapies still ends in CKD or ESRD for too many patients. This revie…
m.cjasn.asnjournals.org
Liquid Biopsy Provides Insights into Lupus
Microparticles in the blood of SLE patients may be a source of extracellular HMGB1, which is involved in immune response. Researchers found that analysis may be…
the-rheumatologist.org

arthritis-research.biomedcentral.com
Urinary Biomarker Index Measures LN Activity Without Biopsy

The Renal Activity Index for Lupus (RAIL) was developed utilizing urinary biomarkers of LN to avoid kidney biopsy.
renalandurologynews.com
MicroRNAs linked to treatment response in lupus nephritis
MELBOURNE – Expression of six microRNAs in kidney biopsy samples helped to predict response to cyclophosphamide.
mdedge.com
Lupus nephritis expert offers management tips
MELBOURNE – Dr. Frédéric Houssiau gives advice on comorbidity management and induction therapy in lupus nephritis, among other things.
mdedge.com
Lupus Nephritis Therapies Reviewed
Singh and colleagues have published a systematic review and Bayesian network metaanalyses of…
Induction and Maintenance Immunosuppression Treatment of Proliferative Lupus Nephritis: A Network Meta-analysis of Randomized Trials

An induction regimen that includes a calcineurin inhibitor can help patients with acute lupus nephritis achieve complete or partial remission, early research suggests.
medscape.com
Aurina Announces Plans for Single Phase III Clinical Trial for Voclosporin

We are devoted to solving the mystery of lupus, one of the world’s cruelest, most unpredictable, and devastating diseases, while giving caring support to those who…
lupus.org
Voclosporin Produces Positive Additive Effects in Patients With Lupus Nephritis
By Chris Berrie…
dgnews.docguide.com
linkinghub.elsevier.com
Review of Lupus Nephritis Supports Eculizumab as a Potential Treatment
Read about a review study that supports eculizumab (Soliris) as a potential new treatment for SLE patients with renal involvement, called lupus nephritis.
lupusnewstoday.com
JAK3-STAT pathway blocking benefits in experimental lupus nephritis
Lupus nephritis (LN) is a complex chronic autoimmune disease of unknown etiology characterized by loss of tolerance against several self-antigens. Cytokines are…
arthritis-research.biomedcentral.com